Patent details

EP3326622 Title: MODIFIED AXL PEPTIDES AND THEIR USE IN INHIBITION OF AXL SIGNALING IN ANTI-METASTATIC THERAPY

Basic Information

Publication number:
EP3326622
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP171966625
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MODIFIED AXL PEPTIDES AND THEIR USE IN INHIBITION OF AXL SIGNALING IN ANTI-METASTATIC THERAPY
French Title of Invention:
PEPTIDES AXL MODIFIÉS ET LEUR UTILISATION DANS L'INHIBITION DE LA SIGNALISATION AXL DANS UNE THÉRAPIE ANTIMÉTASTATIQUE
German Title of Invention:
MODIFIZIERTE AXL-PEPTIDE UND DEREN VERWENDUNG IN DER HEMMUNG DER AXL-SIGNALISIERUNG IN EINER ANTIMETASTATISCHEN THERAPIE
SPC Number:

Dates

Filing date:
12/12/2013
Grant date:
20/01/2021
EP Publication Date:
30/05/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/01/2021
EP B1 Publication Date:
20/01/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/12/2024
Expiration date:
12/12/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/04/2021
 
 

Name:
Aravive Biologics, Inc.
Address:
River Oaks Tower 3730 Kirby Drive, Suite 1200, Houston, TX 77098, United States (US)

Name:
The Board of Trustees of the Leland Stanford Junior University
Address:
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, United States (US)

History of Owners

From:
13/01/2021
To:
16/04/2021

Name:
Aravive Biologics, Inc.
Address:
LyondellBasell Tower 1221 McKinney, Suite 3200, Houston, TX 77010, United States (US)

Name:
The Board of Trustees of the Leland Stanford Junior University
Address:
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
17/03/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
COCHRAN, Jennifer R.
Address:
United States (US)

2

Name:
GIACCIA, Amato J.
Address:
United States (US)

3

Name:
JONES, Douglas
Address:
United States (US)

4

Name:
FUH, Katherine
Address:
United States (US)

5

Name:
MIAO, Yu
Address:
United States (US)

6

Name:
RANKIN, Erinn Bruno
Address:
United States (US)

7

Name:
KARIOLIS, Mihalis
Address:
United States (US)

8

Name:
HERSHENSON, Susan
Address:
United States (US)

Priority

Priority Number:
201261737276 P
Priority Date:
14/12/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/00; A61P 35/00; C07K 14/47; C07K 16/18; C07K 16/28; C07K 16/40;

Publication

European Patent Bulletin

1

Issue number:
202103
Publication date:
20/01/2021
Description:
Grant (B1)

2

Issue number:
202120
Publication date:
19/05/2021
Description:
Change of owner's name or address

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
28/11/2023
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
17/03/2021 Power Of Attorney 1
22/03/2021 Outgoing Correspondence 1